Sale of medicines advances 9.7%

The sale of medicines and drugs not the Brazilian Association of logistics and Distribution of pharmaceutical products (Abradilan) totaled R $3.8 billion between January and August, a rise of 9.7% compared to the previous year. The data, which gathers information from 140 distributors of medicines, toiletries and cosmetics that are associated with that entity in August last Abradilan associated sales reached the mark of R $512.4 million, which represents an increase of 9.2% compared to 2017, when the amount was R $469.4 million. According to the survey, when analyzed the number of units sold in the eighth month of 2018, was registered to 97.3 million products sold, in front of 90.9 million of 2017, an increase of about 7%. The data, which were compiled by the IQVIA, former Quintiles IMS Holdings, also highlights that in the past 12 months, namely, from August to August 2017 2018, sales totaled $5.6 billion, 11.4% R more than the same period of the previous year comparison When they came to R $5 billion. " In units sold, were about 1 billion in 2018 and 983 million in 2017, "detailed the report signed by IQVIA. Distribution of generic products segments in Abradilan in August and similar generic drugs represent 42.6% of sales in values. In units, the percentage is slightly higher, 44.3%. In the same month, the survey pointed out that members reach 84% of the approximately 77000 pharmacies in Brazil.